Plasma neuropeptide-Y concentrations in humans exposed to military survival training

Biological Psychiatry

Volumn 47, Issue 10, 2000, Pages 902-909

  Morgan III, Charles A ^a   Wang, Sheila ^a,b   Southwick, Steven M ^a,b   Rasmusson, Ann ^a,b   Hazlett, Gary ^c   Hauger, Richard L ^d   Charney, Dennis S ^a,b  

^a National Center for PTSD   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JFK Special Warfare Training Center and School   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cortisol; Military stress; PTSD; Special Forces; Stess resilience

Indexed keywords

HYDROCORTISONE; NEUROPEPTIDE Y;

ADULT; ARMY; ARTICLE; CONTROLLED STUDY; HUMAN; MALE; MENTAL STRESS; NORMAL HUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SURVIVAL; TRAINING;

ADULT; BRAIN; HUMANS; HYDROCORTISONE; MALE; MILITARY PERSONNEL; NEUROPEPTIDE Y; STRESS; STRESS DISORDERS, POST-TRAUMATIC; SURVIVAL;

EID: 0034014168     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00239-5     Document Type: Article

References (35)

1. Allen R., Boublik J., Hauger R., Scott H., Rivier J., Brown M. Neuropeptide Y radio-immunoassay Charaterization and application . Clin Exp Pharmacol Physiol. 18:1991;825-833.
2. Bremner J.D., Krystal J.H., Putnam F.W., Southwick S.M., Marmar C., Charney D.S., et al. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Traumatic Stress. 11:1998;125-136.
3. Britten K.T., Southerland S., Van Uden E., Kirby D., Rivier J., Koob G. Anxiolytic activity of NPY receptor agaonists in the conflict test. Psychopharmacol. 132:1997;6-13.
4. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol. 6:1995;215-222.
5. Chatterton R.T. Jr, Vogelson K.M., Lu Y.C., Hudgens G.A. Hormonal responses to psychological stress in men preparing for skydiving. J Clinical Endocrinol Metab. 82:1997;2503-2509.
6. Corder R., Castagne V., Rivet J.-M., Mormede P., Gaillard R.C. Central and peripheral effects of repeated stress and high NaCl diet on neuropeptide Y. Physiol Behav. 52:1992;205-210.
7. Dotsch J., Adelmann M., Englaro P., Dotsch A., Hanze J., Blum W.F., et al. Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid. J Neurol Sci. 151:1997;185-188.
8. Ehlers C.L., Somes C., Siefritz E., Rivier J.E. CRF/NPY interactions A potential role in sleep dysregulation in depression and anxiety . Depression Anxiety. 6:1997;1-9.
9. Flood J.F., Baker M.L., Hernandez E.N., Morley J.E. Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain Res. 503:1989;73-82.
10. Heilig M., Koob G.F., Britton K.T. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides, in an operant conflict test. Reg Peptides. 41:1992;65-69.
11. Heilig M., Murrison R. Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosions in the rat. Eur J Pharmacol. 137:1987;127-129.
12. 1 receptors in the anygdala, and dissociation from food effects . Neuropsychopharmacology. 98:1993;357-363.
13. Heilig M., Widerlov E. Neuropeptide Y An overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses . Acta Psychiatr Scand. 82:1990;95-114.
14. Illes P., Regenold J. Interaction between neuropeptide Y and noradrenaline on central catecholamine neurons. Nature. 334:1990;62-63.
15. Jahng J.W., Houpt T.A., Joh T.H., Wessel T.C. Expression of catecholamine-synthesizing enzymes, peptidylglycine α-amidating monooxygenase, and neuropeptide Y mRNA in the rat adrenal medulla after acute systemic nicotine. J Molec Neurosci. 7:1997;45-52.
16. Kaijser L., Pernow J., Berglund B., Lundberg J.M. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia. Clin Physiol. 10:1990;179-188.
17. Kaye W.H., Berrettini W., Gwirtsman H., George D.T. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry. 47:1990;548-556.
18. Kopin I.J., Gordon E.K., Jimerson D.C., Polinski R.J. Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenethylenneglycol. Science. 219:1983;73-75.
19. Leedy M.G., Wilson M.S. Testosterone and cortisol levels in crewman of U.S. Air Force fighter and cargo planes. Psychosomat Med. 47:1985;333-338.
20. Leino T., Leppaluoto J., Huttunen P., Ruokonen A., Kuronen P. Neuroendocrine responses to real and simulated BA Hawk MK 51 flight. Aviation Space Environ Med. 66:1995;108-113.
21. Lundberg J.M., Martinsson A., Hemsen A., Theodorsson-Norheim E., Svedenhag J., Ekblom B., Hjemdahl P. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun. 133:1985;30-36.
22. Morris M.J., Russell A.E., Kapoor V., Elliott J.M., West M.J., Wing L.M.H., et al. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J Auton Nerv System. 17:1986;143-149.
23. Nakajima M., Inui A., Teranishi A., Miura M., Hirosue Y., Okita M., et al. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice. J Pharmacol Exp Ther. 268:1994;1010-1014.
24. Opstad P.K. Androgenic hormones during prolonged physical stress, sleep and energy deficiency. J Clin Endocrinol Metab. 74:1992;1176-1183.
25. Parker L., Eugene J., Farber D., Lifrak E., Lai M., Juler G. Dissociation of adrenal androgen and cortisol levels in acute stress. Horm Metab Res. 17:1985;209-212.
26. Pernow J., Lundberg J.M., Kaijser L., Hjemdahl P., Theodorsson-Norhem E., Martinsson A., et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol. 6:1986;561-578.
27. Rasmusson A.M., Southwick S.M., Hauger R.L., Charney D.S. Plasma neuropeptide Y (NPY) increases in humans in response to the α-2 antatgonist yohimbine. Neuropsychopharmacol. 19:1998;95-98.
28. Rasmusson A.M., Hauger R.L., Morgan C.A. III, Bremner J.D., Charney D.S., Southwick S.M. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry. 47:2000;526-539.
29. Stanley B.G., Leibowitz S.F. Neuropeptide Y injected in a paraventricular hypothalamus A powerful stimulant of feeding behavior . Proc Natl Acad Sci U S A. 82:1985;3940-3943.
30. Torda T., Cruciani R.A., Saavedra J. Localization of neuropeptide Y binding sites in the zona glomerulosa of the bovine adrenal gland. Neuroendocrinol. 48:1988;207-210.
31. Wahlestedt C., Reis D.J. Neuropeptide Y-related peptides and their receptors Are the receptors potential therapeutic drug targets? Ann Rev Pharmacol Toxicol. 32:1993;309-352.
32. 1 receptors by antisense oligodeoxynucleotides. Science. 259:1993;528-530.
33. Widdowson P.S., Ordway G.A., Halaris A.E. Reduced neuropeptide Y concentrations in suicide brain. J Neurochem. 59:1992;73-80.
34. Widerlov D., Lindstrom L.H., Wahlestedt C., Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal markers for major depression and schizophrenia, respectively. J Psychiatr Res. 22:1988;69-79.
35. Zukowska-Grojec Z., Pruszczyk P., Colton C., Yao J., Shen G.H., Myers A.K., et al. Mitogenic effect of neuropeptide Y in rat vascular smooth muscled cells. Peptides. 14:1993;263-268.